Low‐dose aspirin (LDA) is recommended for thrombophilic predispositions, such as antiphospholipid antibodies that do not completely meet the Sydney classification criteria for APS, protein S deficiency, factor XII deficiency and increased platelet aggregation. Here, PROS1 is linked to hyperinsulinemic hypoglycemia, familial, 4.